Memantine and Intensive Speech-Language Therapy in Aphasia

Completed

Phase 4 Results N/A

Summary of Purpose

- Aphasia, the loss or impairment of language caused by brain damage, is one of the most devastating cognitive impairments of stroke. Aphasia can be treated with combination of speech-language therapy and drugs. Conventional speech-language therapy in chronic aphasic subjects is of little help and several drugs have been studied with limited success. Therefore other therapeutic strategies are...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 20 March 2008.

1 Mar 2005 17 Mar 2008 1 Nov 2007 1 Nov 2007 1 Mar 2008 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Caregiver, Investigator)
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment

Contacts

Not available